Calix, Inc. — Q3 2014 Form 10-Q
Reporting period: Quarter ended September 27, 2014; year-to-date figures cover the nine months ended that date. Comparatives are the corresponding 2013 periods. Amounts are in U.S. dollars.
Business context
Calix provides broadband access systems and software for communications service providers (CSPs). Management cited more than 19 million deployed Unified Access ports and customers whose networks serve over 100 million subscriber lines. Revenue is principally U.S.-based; the United States represented approximately 87% of revenue in both the quarter and nine-month period.
Key financial results
| Metric | Q3 2014 | Q3 2013 | Nine months 2014 | Nine months 2013 |
|---|---|---|---|---|
| Revenue | $105.8 million | $103.6 million | $289.6 million | $288.6 million |
| Gross profit / margin | $45.1 million / 43% | $47.4 million / 46% | $126.3 million / 44% | $131.0 million / 45% |
| Operating loss | $3.7 million | $0.01 million | $17.5 million | $10.4 million |
| Net income (loss) | $(3.8) million | $0.5 million | $(17.8) million | $(10.8) million |
| Net loss per share, diluted | $(0.08) | $.01 income | $(0.35) | $(0.22) |
| Operating cash flow | Not stated for quarter | Not stated for quarter | $14.5 million | $36.8 million |
- Profitability and costs: Q3 revenue increased 2%, but gross profit declined 5%. Nine-month revenue was nearly flat while gross profit fell 4%. Cost of revenue rose 8% in Q3 and 4% year to date. Operating expenses were $48.8 million in Q3 and $143.9 million year to date.
- Cash and liquidity: At September 27, cash and cash equivalents were $39.4 million and marketable securities were $48.4 million, for combined cash, cash equivalents and securities of $87.8 million. Current assets were $192.5 million versus current liabilities of $70.9 million. Cash and cash equivalents declined $43.3 million in the first nine months.
- Cash flow and investment: Nine-month investing cash outflow was $58.2 million, including net marketable-security purchases of approximately $48.7 million and $9.5 million of capital expenditures. Financing provided $0.4 million.
- Debt and facility: Calix had no borrowings under its $50 million revolving credit facility, which matures in July 2016; the full amount was available at quarter-end. The facility is secured by substantially all assets, including intellectual property. Calix reported compliance with its financial covenants. Restricted cash of $0.3 million collateralized legacy letters of credit.
- Other balance-sheet items: Deferred revenue totaled $38.9 million, down from $53.3 million at December 31, 2013. Accumulated deficit was $527.6 million. The company reported no off-balance-sheet arrangements.
Material changes and management commentary
- Q3 revenue benefited from stronger bookings and shipments across territories and recognition of revenue after customer acceptance of certain Broadband Stimulus-funded projects. Nine-month revenue was essentially flat; stronger bookings were offset by lower deferred-revenue recognition than in 2013.
- Inventory write-downs were $2.1 million in Q3 and $4.7 million for the first nine months, versus $0.2 million and $0.5 million in the comparable 2013 periods. The 2014 charges related primarily to weaker-than-expected growth in sales of Ericsson-acquired products for markets outside North America, as well as other slow-moving inventory. Management expected lower write-downs in future periods and did not expect a similar gross-margin impact.
- Sales and marketing expense rose 13% in Q3 and 10% year to date, primarily reflecting increased staffing and related costs to support domestic and international expansion. R&D expense was broadly steady; management said it would continue investing in the Unified Access portfolio. G&A expense declined, in part because of lower stock-based compensation.
- Management stated that existing cash, securities and available credit were expected to cover anticipated needs for at least 12 months. The filing provides no specific revenue or earnings guidance. Management noted that results can fluctuate due to CSP spending cycles, customer budgets, product and customer mix, and the timing of deferred-revenue recognition.
Risks, contingencies and unusual items
- Profitability: Calix reported a nine-month net loss, has a history of losses, and cautioned that it may not achieve or sustain profitability or positive operating cash flow.
- Customer and market exposure: A single customer represented 10% of Q3 revenue; the filing does not identify that customer in this disclosure. CSP capital spending, customer concentration, competition, sales-cycle variability and limited committed-volume contracts may affect results.
- Project and revenue timing: Revenue recognition can depend on customer acceptance, including for government-funded projects. RUS-funded projects were required to be completed by June 30, 2015; funding and project timing may affect purchasing and reported revenue.
- Inventory and margins: Product mix, competitive pricing, inventory obsolescence and further write-downs may pressure gross margins. Calix also relies on contract manufacturers and certain sole- or limited-source suppliers.
- Pending litigation: A class action relating to the 2011 Occam merger remains pending. The court left certain claims against Occam’s former CEO and CFO and disclosure-related claims in place; a trial was scheduled for February 16, 2015. Calix intends to contest the case, but said potential indemnification exposure could not be quantified and an adverse result could materially affect the company.
- Taxes: Calix maintained a full valuation allowance against net deferred tax assets, except for certain foreign deferred tax assets. Unrecognized tax benefits were $14.8 million at quarter-end.
- Controls: Management concluded disclosure controls were effective at a reasonable-assurance level and reported no material change in internal control over financial reporting during the quarter.
Investor verification priorities
- Track inventory levels, the source and recurrence of write-downs, and whether gross margins recover as management expected.
- Assess the timing and amount of deferred-revenue recognition, especially customer acceptance of RUS- and other stimulus-funded projects.
- Monitor operating cash generation against reported losses, capital spending, and the use of the credit facility; confirm continued covenant compliance.
- Follow the Occam litigation, trial developments, and any change in the currently unquantified indemnification exposure.
- Verify customer concentration and the sustainability of revenue growth as Calix expands internationally and invests in sales, marketing and R&D.